Intel beats VLSI in $3.1bn Texas suit

Managing IP is part of Legal Benchmarking Limited, 1-2 Paris Gardens, London, SE1 8ND

Copyright © Legal Benchmarking Limited and its affiliated companies 2026

Accessibility | Terms of Use | Privacy Policy | Modern Slavery Statement

Intel beats VLSI in $3.1bn Texas suit

adobestock-288834591-editorial-use-only.jpeg

In the second trial of three, Intel punches back at VLSI after a $2.18 billion verdict from the same court in March

In a surprise turn of events at the District Court for the Western District of Texas yesterday, April 21, a jury ruled in favour of Intel in the tech company’s second patent trial against VLSI Technology, in which the latter was seeking $3.1 billion in damages.

The news comes less than two months after a jury in the same court ruled against Intel, delivering a record-breaking $2.18 billion damages award to VLSI, a unit of the hedge fund Fortress Investment Group.

Intel is seeking a new trial in that case, and has said it intends to appeal the $2.18 billion verdict.

Related stories

Yesterday’s ruling, made in Waco, was handed down in the fourth patent trial to take place in Alan Albright’s court since his appointment in 2018 and it was the third victory for a defendant. The first was in MV3 v Roku, which ended in December 2020.

VLSI sued Intel at the Western District of Texas in April 2019, alleging that the tech company had infringed its patent pertaining to speed shift technology.

A third trial in Albright’s court over similar patented technology is scheduled for June.

more from across site and SHARED ros bottom lb

More from across our site

Emma Green, partner at Bird & Bird, shares why the Iceland v Iceland dispute could prompt businesses and lawyers to think differently about brand enforcement
Attain IP, developed by two UK patent lawyers, will meet ‘forensic’ needs of patent attorneys by showing a verifiable reasoning chain, according to its co-founders
The High Court of Australia has allowed a fashion designer to retain her registered ‘Katie Perry’ trademark for clothing
Sim & San secured the win for Dr. Reddy’s, which will allow the pharma company to manufacture and export semaglutide, the active ingredient in Ozempic
Lucas Amodio joins our ‘Five minutes with’ series to discuss artificial intelligence systems and patent law
The Americas research cycle has commenced, so don't miss the opportunity to submit your work
Practitioners have welcomed extended funding of the specialist police unit until 2029, while the UKIPO says it is exploring increased scale
Abion says integration with Baylos marks an important step in the company’s international expansion plans
Via Licensing Alliance continues its China push as another smartphone manufacturer joins patent pool as licensee
Law firm mergers have the potential to reshape IP teams, and partners who were at the coalface of previous tie-ups say early coordination and flexibility can make the difference
Gift this article